Compare PLTK & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLTK | ENOV |
|---|---|---|
| Founded | 2010 | 1995 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Fluid Controls |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2020 | 2008 |
| Metric | PLTK | ENOV |
|---|---|---|
| Price | $3.13 | $21.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | $5.04 | ★ $47.38 |
| AVG Volume (30 Days) | ★ 1.3M | 980.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 11.46% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | N/A |
| Revenue | ★ $2,755,400,000.00 | N/A |
| Revenue This Year | $2.60 | $6.36 |
| Revenue Next Year | $2.23 | $5.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.08 | N/A |
| 52 Week Low | $2.64 | $20.82 |
| 52 Week High | $5.05 | $36.82 |
| Indicator | PLTK | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 38.48 |
| Support Level | $2.64 | N/A |
| Resistance Level | $3.80 | $27.11 |
| Average True Range (ATR) | 0.17 | 1.19 |
| MACD | -0.05 | -0.16 |
| Stochastic Oscillator | 21.05 | 15.19 |
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.